This text is a result of machine translation.
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
Ganli pharmaceutical won the bid for centralized procurement of insulin glargine injection
New Import Tax Regulations in Brazil: Cross-Border Shopping to Enjoy Tax Discounts
EqualOcean reports that starting August 1, 2024, under Brazil's newly passed Law No. 914/2024, purchases over USD 50 on international cross-border shopping platforms that are part of the "Conforme Remessa" import tax compliance program will benefit from reduced import taxes.
Jul 09, 2024 07:13 PM
Special national collection of insulin: Ganli pharmaceutical Ganjing and asparagus insulin all reported the lowest prices: 48.71 yuan and 19.98 yuan
Robin Li: Baidu has become the world's largest automated driving service provider.
During the 14th Five Year Plan period, China will restore 230 million mu of degraded grassland
Pharmaceutical and biological stocks fell sharply in early trading